Meet the Visionaries Leading the Future of Precision Medicine
At the American Board of Precision Medicine (ABOPM), our executive team brings together pioneers in science, healthcare, education, and technology. With decades of combined experience and a shared commitment to innovation, these leaders are shaping the strategic direction of ABOPM — driving our mission to advance multi-omics, systems biology, and personalized care for a healthier world.

Executive Team

  • Dr. Matthew Taylor is a board-certified family physician and exemplar of P4 precision medicine in clinical practice, sought as a domain expert and clinical mentor among integrative and personalized medicine practitioners multinationally. A depth of training and experience in multiple disciplines informs both his innovative approaches to whole precision care of the complex chronically ill and sapient perspectives on precision medicine acumen and professional development.

    Dr. Taylor earned his medical degree from Wayne State University School of Medicine, and trained in full-spectrum Family Medicine both at UPMC Altoona Family Physicians and the University of Maryland Medical Center. He continued into private practice, concurrently engaged in protean training intensives across several organizations, including the National Lipidology Association, SSRP Cellular Medicine Fellowship, Institute for Functional Medicine, Trauma Research Foundation, National Institute for the Clinical Application of Behavioral Medicine (NICABM), and International Society for Environmentally Acquired Illness (ISEAI).

    As a cofounder of the American Board of Precision Medicine (ABOPM) and its Director of Network Analysis, Dr. Taylor aims to ensure alignment of medical and scientific teams’ objectives with overall organizational strategy and quality of education disseminated to board diplomate candidates. He brings robust clinical and strategic experience from private, hospital, and healthcare startup ecosystems, compassionate presence from a host of health journeys of the undiagnosed and unhealed, partnership in their transformational outcomes, and a devotion to the ABOPM's paradigm-shifting medical mission. He is the father of four beautiful children, seeking to empower them in drive, faith, and love.

Co-founder | Chief Medical Officer

  • Medical & Education Director | Keynote Speaker | Industry Advisor | Global Health Strategist

    Dr. Tabatha Parker is a visionary leader in the global integrative and functional medicine movement, with a strong record of success as a Medical Director, Education Executive, and Strategic Consultant. She has designed, led, and scaled educational and clinical programs across the supplement, wellness, and nonprofit health sectors—driving thought leadership and strategic growth for mission-aligned organizations.

    Parker has served in executive roles for nearly two decades, including Executive Director, Director of Education, and Associate Fellowship Director for the Academy of Integrative Health & Medicine (AIHM), where she helped build one of the world’s leading integrative health fellowships. She led the development of over 1,300 hours of CME/CEU-accredited education for interprofessional audiences, and co-chaired high-profile conferences featuring hundreds of global speakers and partners, generating millions in revenue and impact.

    She is a recognized medical education architect, having co-chaired the first Global Health Master’s Program at National University of Natural Medicine (NUNM), created global service-learning programs, and led the development of international fellowships. Her career includes directing international medical relief clinics, curriculum development for natural health universities, and consulting for supplement brands and wellness startups.

    As Founding Co-Secretary General of the World Naturopathic Federation, Parker represented the profession at multiple World Health Assemblies and was a key contributor to the WHO Benchmarks for Training in Naturopathy. She has engaged with Ministries of Health and multilateral agencies like WHO and PAHO to embed traditional and integrative medicine into national health strategies.

    She has delivered keynotes at integrative and functional medicine conferences around the world, bringing together global stakeholders and innovators. In her clinical career, she founded and directed Natural Doctors International (NDI), the first international naturopathic service-relief organization, where she served over 20,000 patients in Nicaragua and led global medical brigades and internship programs with a focus on integrative, whole-person care.

    Her recognitions include:

    • Physician of the Year – American Association of Naturopathic Physicians (AANP)

    • Magistra Natura – Highest naturopathic honor in Spain

    • Visionary of the YearUTNE Reader

    • Honorary ND Degree – Canadian College of Naturopathic Medicine

    Currently, she serves as an advisor to multiple global health and industry organizations, including the TCIH Coalition, TecSalud Mexico, the Consciousness and Healing Initiative, and TXAND (Treasurer). She remains active in global health strategy, having co-authored a widely cited 2023 BMJ Global Health article on WHO’s future strategy for Traditional, Complementary, and Integrative Medicine.

    Dr. Parker is a bilingual (English/Spanish) naturopathic physician and visionary leader in integrative and functional medicine. A stellar networker, she is deeply connected across the global health and wellness community and is now focusing her expertise at the intersection of AI and health—helping to shape the future of functional and integrative medicine.

    Renowned for her strategic thinking and deep expertise in education, Dr. Parker is a sought-after consultant and advisor for organizations aiming to grow, innovate, and lead in medical education, clinical research, and systems transformation. She brings decades of experience advancing curriculum design, workforce development, and health equity.

    Dr. Parker would be an exceptional asset to any supplement company or health industry brand seeking to elevate their educational strategy, expand outreach, and accelerate growth. Her bright, friendly nature and collaborative spirit make her a joy to have on any team.

    She is available for leadership roles in education strategy, clinical innovation, product development, keynote speaking, and advisory work across the integrative health and wellness sectors.

Chief Operating Officer

  • Dr. Puya Yazdi is a physician-scientist and accomplished entrepreneur with over 15 years of proven experience bridging clinical medicine, genomics, bioinformatics, and artificial intelligence to transform healthcare. His professional mission is to harness the power and promise of genomics and AI-driven precision medicine to improve health outcomes on a global scale.

    Dr. Yazdi earned his undergraduate degree from the University of California, Irvine, followed by his Medical Doctorate from the University of Southern California, and his residency at Stanford University. He was awarded the prestigious California Institute of Regenerative Medicine Clinical Fellowship at UC Irvine, where he spearheaded groundbreaking research in stem cells, epigenomics, and genomics. His contributions to science include numerous peer-reviewed publications, several intellectual property filings, and invited speaking engagements at leading international conferences and organizations.

    As the founder and CEO/CSO of Systomic Health, Dr. Yazdi successfully developed and commercialized advanced genomics, bioinformatics, and precision medicine solutions. His leadership culminated in delivering innovative technologies and clinical insights to prestigious clients such as Allergan, Caladrius Biosciences, and Omega Protein. His expertise in clinical trial design, regulatory affairs, and multi-omics data analysis established him as a trusted partner in the biotechnology and pharmaceutical sectors.

    Currently serving as the Chief Science Officer and Chief Medical Officer at SelfDecode, Dr. Yazdi has assembled and led a dynamic, multidisciplinary team of AI/ML scientists, bioinformaticians, and clinical researchers. Under his strategic direction, SelfDecode has become an industry leader, pioneering AI-driven genomic technologies that deliver substantial improvements in genetic risk predictions, pharmacogenomics, and precision health applications. His innovations have resulted in patents, significant revenue growth, and a highly respected platform utilized worldwide.

    Dr. Yazdi’s approach to leadership is deeply inspired by pioneering thinkers such as Richard Feynman, emphasizing clarity, curiosity, and collaborative innovation. He excels in translating complex scientific concepts into impactful healthcare solutions, fostering high-performing teams that adapt, persevere, and achieve groundbreaking advancements in genomics and precision medicine.

    Through his ongoing endeavors, Dr. Yazdi continues to redefine the intersection of technology and healthcare, demonstrating an unwavering commitment to making precision medicine accessible and transformative for all.

Chief Technology Officer | Chief Medical Officer